I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 4 studies | 20% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 2% | |
| epithelial cell | 4 studies | 34% ± 11% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 18% ± 2% | |
| gamma-delta T cell | 4 studies | 22% ± 9% | |
| B cell | 3 studies | 17% ± 2% | |
| classical monocyte | 3 studies | 18% ± 2% | |
| conventional dendritic cell | 3 studies | 24% ± 6% | |
| non-classical monocyte | 3 studies | 23% ± 8% | |
| fibroblast | 3 studies | 21% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
| dendritic cell | 3 studies | 33% ± 12% | |
| goblet cell | 3 studies | 16% ± 1% |
